Three of the eight studies with low risk of bias assessed immunoassays for evaluation of anti‐platelet IgM antibodies, two in newly diagnosed ITP and one in chronic ITP (Table 3; full results, Table S6). Here, CD40LG is linked to autoimmune thrombocytopenic purpura.